Cargando…
Crystal structure of the thalidomide analog (3aR*,7aS*)-2-(2,6-dioxopiperidin-3-yl)hexahydro-1H-isoindole-1,3(2H)-dione
The title compound, C(13)H(16)N(2)O(4), crystallizes in the monoclinic centrosymmetric space group, P2(1)/c, with four molecules in the asymmetric unit, thus there is no crystallographically imposed symmetry and it is a racemic mixture. The structure consists of a six-membered unsaturated ring boun...
Autores principales: | Hijji, Yousef, Benjamin, Ellis, Jasinski, Jerry P., Butcher, Ray J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218906/ https://www.ncbi.nlm.nih.gov/pubmed/30443388 http://dx.doi.org/10.1107/S2056989018014317 |
Ejemplares similares
-
3-(2,6-Dioxopiperidin-3-yl)-3-azabicyclo[3.2.0]heptane-2,4-dione
por: Hijji, Yousef M., et al.
Publicado: (2009) -
2-Tosyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]isoindol-1-one
por: Wu, Min, et al.
Publicado: (2013) -
2-(4-Methylphenyl)-3-oxo-4-phenyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]isoindole-6-carbonitrile
por: Wen, Lei, et al.
Publicado: (2013) -
2-(2,3-Dimethylphenyl)-1H-isoindole-1,3(2H)-dione
por: Tariq, Muhammad Ilyas, et al.
Publicado: (2010) -
(3aR,6S,7aR)-7a-Bromo-2-methylsulfonyl-1,2,3,6,7,7a-hexahydro-3a,6-epoxyisoindole
por: Temel, Ersin, et al.
Publicado: (2011)